31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
FASB has issued an Invitation to Comment, or ITC, as part of FASB’s project on certain identifiabl...
Read More >
Although the Federal Arbitration Act (“FAA”) places arbitration agreements on the same footing as ...
Read More >
Seyfarth Synopsis: As the Massachusetts Paid Family and Medical Leave (“PFML”) law enters the firs...
Read More >
El 23 de Octubre de 2019 entró en vigor la NOM-35-STPS de la Secretaría del Trabajo y Previsión Soci...
Read More >
On June 13, 2019, the Departments of Treasury, Labor, and Health and Human Services issued final reg...
Read More >
This is the first in a series of posts we’ll be writing for governments thinking of utilizing the P...
Read More >